{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:12:49Z","timestamp":1783599169687,"version":"3.55.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Diffuse large B-cell lymphoma (DLBCL) as among the most common lymphomas is associated with insulin resistance (IR). The triglyceride-glucose (TyG) index, generally considered a surrogate marker for IR, has an uncertain prognostic value in DLBCL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective analysis of DLBCL patients who received R-CHOP therapy at the Second Affiliated Hospital of Nanchang University from January 2011 to December 2023. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic factors for overall survival (OS). Boruta algorithm was employed to strengthen the robustness of our analysis. Restricted cubic spline (RCS) analysis was used to explore the potential nonlinear relationship between the TyG index and OS. Subgroup analyses were conducted to assess the prognostic value of the TyG index across different patient subgroups. Finally, a nomogram model based on the TyG index was developed, and its predictive performance was evaluated using the area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis (DCA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 186 DLBCL patients were included in this study. Univariate and multivariate Cox regression analyses identified the TyG index, Age, ECOG performance status, Ann Arbor stage, and lactate dehydrogenase levels as independent prognostic factors for DLBCL. The Boruta algorithm confirmed these variables as the most important prognostic factors. Kaplan-Meier analysis revealed significantly poorer OS in the high TyG index group. RCS analysis demonstrated a non-linear relationship between the TyG index and OS. Subgroup analyses further validated the TyG index as a significant prognostic factor across various patient subgroups. The TyG-based nomogram model outperformed the conventional International Prognostic Index (IPI), with AUROCs of 0.878, 0.809, and 0.867 for 1-year, 3-year, and 5-year OS, respectively. Calibration curves showed good agreement between the nomogram predictions and actual outcomes, and DCA highlighted the high clinical utility of the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The TyG index is an independent prognostic factor in DLBCL patients, and the TyG-based nomogram model provides enhanced predictive accuracy compared to the IPI. Its simplicity and low cost make it a valuable tool for routine clinical prognostic assessment in DLBCL patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1573986","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:13:43Z","timestamp":1745813623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["An analysis of the relationship of triglyceride glucose index with diffuse large B-cell lymphoma prognosis: a retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"QingQing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhou","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008239","article-title":"How I treat older patients with DLBCL in the frontline setting","volume":"141","author":"Lugtenburg","year":"2023","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v130.8","article-title":"Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray","volume":"130","author":"Dai","year":"2024","journal-title":"Cancer."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-023-01358-y","article-title":"Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma","volume":"8","author":"Shen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02833-1","article-title":"Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer","volume":"131","author":"Javed","year":"2024","journal-title":"Br J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11154-023-09849-7","article-title":"Thyroid cancer and insulin resistance","volume":"25","author":"Brenta","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"B7","article-title":"Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma","volume":"13","author":"Yu","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"216877","DOI":"10.1016\/j.canlet.2024.216877","article-title":"PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma","volume":"591","author":"Liang","year":"2024","journal-title":"Cancer Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment","volume":"136","author":"Kobayashi","year":"2020","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/metabo13060734","article-title":"The metabolism and immune environment in diffuse large B-cell lymphoma","volume":"13","author":"Wu","year":"2023","journal-title":"Metabolites"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31373","article-title":"Associations between statin use and risk of non-Hodgkin lymphomas by subtype","volume":"143","author":"Ye","year":"2018","journal-title":"Int J Cancer."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.23.04108-8","article-title":"Post-COVID-19 syndrome, inflammation and insulin resistance: a retrospective cohort study","author":"Fierro","year":"2024","journal-title":"Minerva Endocrinol (Torino)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13098-025-01616-9","article-title":"Triglyceride glucose-waist circumference as a predictor of mortality and subtypes of cardiovascular disease: a systematic review and meta-analysis","volume":"17","author":"Rabiee Rad","year":"2025","journal-title":"Diabetol Metab Syndr."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.20.03273-3","article-title":"The triglyceride glucose index and CDKAL1 gene rs10946398 SNP are associated with NAFLD in Chinese adults","volume":"48","author":"Zhu","year":"2023","journal-title":"Minerva Endocrinol (Torino)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12944-024-02008-0","article-title":"Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study","volume":"23","author":"Zhang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02526-1","article-title":"Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts","volume":"130","author":"Fritz","year":"2024","journal-title":"Br J Cancer."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.585388","article-title":"Association between triglyceride glucose index and non-small cell lung cancer risk in chinese population","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10120-021-01222-4","article-title":"Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study","volume":"25","author":"Kim","year":"2022","journal-title":"Gastric Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.3390\/ijms222011137","article-title":"Insulin resistance and cancer: in search for a causal link","volume":"22","author":"Chiefari","year":"2021","journal-title":". Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16313","article-title":"Association of triglyceride-glucose index with the risk of prostate cancer: a retrospective study","volume":"11","author":"Li","year":"2023","journal-title":"PeerJ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12889-024-18076-x","article-title":"Association of the triglyceride-glucose index with the occurrence and recurrence of colorectal adenomas: a retrospective study from China","volume":"24","author":"Li","year":"2024","journal-title":"BMC Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"101135","DOI":"10.1016\/j.lanwpc.2024.101135","article-title":"Association of the triglyceride-glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China","volume":"49","author":"He","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2023.04.411","article-title":"Insulin resistance and the prognosis in diffuse large B-cell lymphoma","volume":"33","author":"Zhou","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0324","article-title":"Insulin resistance and cancer: the role of insulin and IGFs","volume":"20","author":"Djiogue","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1440","article-title":"Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I","volume":"148","author":"Maile","year":"2007","journal-title":"Endocrinology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"110691","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","article-title":"Mechanisms of oxidative stress in metabolic syndrome","volume":"24","author":"Masenga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.67892","article-title":"Advances in multi-omics study of prognostic biomarkers of diffuse large B-cell lymphoma","volume":"18","author":"Liang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13550-023-01047-5","article-title":"Baseline 18F-FDG PET\/CT radiomics for prognosis prediction in diffuse large B cell lymphoma","volume":"13","author":"Jing","year":"2023","journal-title":"EJNMMI Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-022-03393-9","article-title":"Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature","volume":"20","author":"He","year":"2022","journal-title":"J Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i32.9825","article-title":"Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients","volume":"9","author":"Wu","year":"2021","journal-title":"World J Clin Cases."},{"key":"B33","article-title":"Prognostic value of multiple immune inflammatory markers in diffuse large B-cell lymphoma","volume":"15","author":"Li","year":"2023","journal-title":"Am J Transl Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1573986\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:13:44Z","timestamp":1745813624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1573986\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":33,"alternative-id":["10.3389\/fendo.2025.1573986"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1573986","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1573986"}}